Longevity Fund

Longevity Fund is an early-stage venture capital fund focused specifically on longevity biotech investments. The fund was founded by Laura Deming, a Thiel Fellow from the 2011 class, who has dedicated her career to advancing research and companies working on extending human healthspan and lifespan.

The aging process leads to numerous health issues and ultimately death, while promising longevity research and biotech companies often struggle to secure funding from traditional investors who may not understand the scientific complexities or long development timelines.